Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.
2.

Multimodality treatment programs for malignant pleural mesothelioma using high-dose hemithorax irradiation.

Mattson K, Holsti LR, Tammilehto L, Maasilta P, Pyrhönen S, Mäntylä M, Kajanti M, Salminen US, Rautonen J, Kivisaari L.

Int J Radiat Oncol Biol Phys. 1992;24(4):643-50.

PMID:
1429086
3.

Altered fractionation of hemithorax irradiation for pleural mesothelioma and failure patterns after treatment.

Holsti LR, Pyrhönen S, Kajanti M, Mäntylä M, Mattson K, Maasilta P, Kivisaari L.

Acta Oncol. 1997;36(4):397-405.

PMID:
9247101
4.

Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients.

Law MR, Gregor A, Hodson ME, Bloom HJ, Turner-Warwick M.

Thorax. 1984 Apr;39(4):255-9.

5.

Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.

Patel PR, Yoo S, Broadwater G, Marks LB, Miles EF, D'Amico TA, Harpole D, Kelsey CR.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):362-8. doi: 10.1016/j.ijrobp.2011.11.057.

PMID:
22516382
6.

Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.

Shin DM, Fossella FV, Umsawasdi T, Murphy WK, Chasen MH, Walsh G, Komaki R, McMurtrey MJ, Hong WK.

Cancer. 1995 Dec 1;76(11):2230-6.

8.

Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma.

Xia H, Karasawa K, Hanyu N, Chang TC, Okamoto M, Kiguchi Y, Kawakami M, Itazawa T.

Int J Hyperthermia. 2006 Nov;22(7):613-21.

PMID:
17079218
9.
10.

Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma: a phase II FONICAP trial. Italian Lung Cancer Task Force.

Pennucci MC, Ardizzoni A, Pronzato P, Fioretti M, Lanfranco C, Verna A, Giorgi G, Vigani A, Frola C, Rosso R.

Cancer. 1997 May 15;79(10):1897-902.

PMID:
9149015
11.

Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomy.

Allen AM, Den R, Wong JS, Zurakowski D, Soto R, Jänne PA, Zellos L, Bueno R, Sugarbaker DJ, Baldini EH.

Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1366-74.

PMID:
17674974
12.

Extrapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma.

Sugarbaker DJ, Heher EC, Lee TH, Couper G, Mentzer S, Corson JM, Collins JJ Jr, Shemin R, Pugatch R, Weissman L, et al.

J Thorac Cardiovasc Surg. 1991 Jul;102(1):10-4; discussion 14-5.

PMID:
2072707
13.

The role of palliative radiotherapy in malignant mesothelioma.

Bissett D, Macbeth FR, Cram I.

Clin Oncol (R Coll Radiol). 1991 Nov;3(6):315-7.

PMID:
1720658
14.

Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution.

Frata P, Buglione M, Grisanti S, Bonetti B, Vitali E, De Stefani A, Magri E, Peveri A, Marini G, Rossi G, Magrini SM.

Tumori. 2005 Nov-Dec;91(6):456-62.

PMID:
16457141
15.

Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura--a single-institution experience with 189 patients.

de Graaf-Strukowska L, van der Zee J, van Putten W, Senan S.

Int J Radiat Oncol Biol Phys. 1999 Feb 1;43(3):511-6.

PMID:
10078630
16.

Chemotherapy for malignant mesothelioma; CAMEO.

Jett JR, Eagan RT.

Am J Clin Oncol. 1982 Aug;5(4):429-31.

PMID:
7051806
17.

Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma.

Lee TT, Everett DL, Shu HK, Jahan TM, Roach M 3rd, Speight JL, Cameron RB, Phillips TL, Chan A, Jablons DM.

J Thorac Cardiovasc Surg. 2002 Dec;124(6):1183-9.

18.

Analysis of the effect of radiotherapy on malignant pleural mesothelioma when given on adjuvant or palliative basis.

El Hossieny HA, Aboulkasem F, Abdel Rahman M.

Zhongguo Fei Ai Za Zhi. 2010 Jan;13(1):54-9. doi: 10.3779/j.issn.1009-3419.2010.01.10.

19.
20.

Outcome and patterns of failure in testicular lymphoma: a multicenter Rare Cancer Network study.

Zouhair A, Weber D, Belkacémi Y, Ketterer N, Dietrich PY, Villà S, Scandolaro L, Bieri S, Studer G, Delacretaz F, Girardet C, Mirimanoff RO, Ozsahin M; Rare Cancer Network.

Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):652-6.

PMID:
11849786

Supplemental Content

Support Center